Results 41 to 50 of about 5,147,229 (341)

Self-sampling and HPV DNA testing for cervical precancer screening in a cohort of nuns in Ghana: a cross-sectional cohort studyResearch in context

open access: yesEClinicalMedicine, 2023
Summary: Background: The need for cervical cancer screening has been emphasised in at-risk cohorts of women to reduce their risk of cervical cancer. Some women with decreased risk of acquiring human papillomavirus (HPV) infections, such as Catholic nuns,
Kofi Effah   +11 more
doaj  

Prediction of cervical lymph node metastases in papillary thyroid microcarcinoma by sonographic features of the primary site

open access: yesCancer Biology & Medicine, 2019
Objective To study the sonographic features of the primary site of papillary thyroid microcarcinoma (PTMC) for the prediction of cervical lymph node metastasis during preoperative diagnosis.Methods A total of 710 PTMC patients between 2013 and 2016 with ...
Xi Wei   +11 more
doaj   +1 more source

Trial of a Rare Diagnosis in a Core Needle Biopsy of Breast

open access: yesClinical Pathology, 2021
Objective: Mucinous carcinoma is a rare, special subtype of breast carcinoma associated with a good prognosis. It often presents a confusing appearance with a benign process. For all these reasons, differential diagnosis could be challenging. Case Report:
Karima Idrissi Serhrouchni   +5 more
doaj   +1 more source

Cervical cancer in low and middle-income countries

open access: yesOncology Letters, 2020
Cervical cancer is a malignant tumour that occurs in the cervix and is classified into two histological types, adenocarcinoma and squamous cell carcinoma (SCC); SCC is more common and accounts for 70% of all cases.
Rodney Hull   +10 more
semanticscholar   +1 more source

Real-world Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.

open access: yesJournal of the National Cancer Institute, 2021
BACKGROUND The primary goal of human papillomavirus (HPV) vaccination is to reduce morbidity and mortality from HPV-associated disease, especially cervical cancer.
S. Kjaer   +3 more
semanticscholar   +1 more source

Human papillomavirus and cervical cancer

open access: yesJournal of Obstetrics and Gynaecology Research, 2019
Cervical cancer is by far the most common HPV-related disease. About 99.7% of cervical cancer cases are caused by persistent genital high-risk human papillomavirus (HPV) infection.
K. Okunade
semanticscholar   +1 more source

Clinical validation of the Roche cobas HPV test on the Roche cobas 5800 system for the purpose of cervical screening

open access: yesMicrobiology Spectrum
This study assessed the relative clinical sensitivity and specificity, as well as reproducibility, for high-risk HPV types of the Roche cobas HPV test when processed using the Roche cobas 5800 system.
Nikita Mehta   +11 more
doaj   +1 more source

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

open access: yesNew England Journal of Medicine, 2018
BACKGROUND There are limited data from retrospective studies regarding whether survival outcomes after laparoscopic or robot‐assisted radical hysterectomy (minimally invasive surgery) are equivalent to those after open abdominal radical hysterectomy ...
P. Ramirez   +19 more
semanticscholar   +1 more source

Cervical cancer: Epidemiology, risk factors and screening

open access: yesChinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2020
Cervical cancer is one of the leading causes of cancer death among females worldwide and its behavior epidemiologically likes a venereal disease of low infectiousness.
Shaokai Zhang   +3 more
semanticscholar   +1 more source

Cervical cancer prevention and control in women living with human immunodeficiency virus

open access: yesCa, 2021
Despite being highly preventable, cervical cancer is the fourth most common cancer and cause of cancer death in women globally. In low‐income countries, cervical cancer is often the leading cause of cancer‐related morbidity and mortality.
P. Castle, M. Einstein, V. Sahasrabuddhe
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy